MAGFER-FC contains Ferric Carboxymaltose 500 mg, an intravenous iron formulation used for the treatment of iron deficiency and iron deficiency anaemia when oral iron preparations are ineffective, not tolerated, or when rapid iron replenishment is clinically appropriate.
Ferric Carboxymaltose provides iron for incorporation into haemoglobin and replenishment of iron stores. It is administered intravenously by a qualified healthcare professional following appropriate clinical assessment.
Composition:
- Ferric Carboxymaltose – 500 mg
- Dosage form: Injection
Key Benefits / Uses:
- Used for iron deficiency and iron deficiency anaemia
- Helps replenish depleted iron stores
- Supports haemoglobin production
- Provides intravenous iron supplementation
- Useful when oral iron therapy is unsuitable or insufficient
- Suitable for clinical use under medical supervision
Important: MAGFER-FC should be administered only by a qualified healthcare professional. Patients should be assessed for iron deficiency before treatment. Appropriate monitoring may be required during and after administration.
